Breaking News

You are here » Indian-Commodity  :  Investment  :  Bombay Dyeing acquires 4.32% stake in Archway

06-Sep2016

Bombay Dyeing acquires 4.32% stake in Archway

Bombay Dyeing & Manufacturing Company (BDMC) has acquired 4.32% of equity share capital amounting 2,24,400 equity shares of Archway Investment Company (Archway) from minority shareholders. By this acquisition, Archway has become wholly owned subsidiary of BDMC.

Bombay Dyeing and Manufacturing Company is a holding company that is engaged in finishing of cotton and blended cotton textiles; manufacturing of bedding, quilts, pillows and sleeping bags; real estate activities, and manufacturing of polyester Staple Fiber (PSF).




Related News

View all news

SpiceJet to start 12 new domestic flights from March 31

SpiceJet will start 12 new direct flights on its domestic network from March 31, 2019. The airline is the first Indian carrier to introduce daily direct flights on the Bhopal-Surat-Bhopal, Gorakhpur-Mumbai-Gorakhpur......

Aditya Birla Fashion to start apparel manufacturing plant in Odisha: Report

Aditya Birla Fashion and Retail is reportedly to start a new apparel manufacturing plant in Rayagda district of Odisha with an investment of Rs 114 crore. This unit will have a capacity to produce 3.6......

Power Grid gets investment approval for 'Northern Region System Strengthening - XL'

Power Grid Corporation of India has received an investment approval for 'Northern Region System Strengthening - XL' at an estimated cost of Rs 572.98 crore with commissioning schedule of 22 months from......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......